Monthly Archives: December 2010
Physical Activity and Risk of Breast Cancer Among Postmenopausal Women
Physical activity has many health benefits, including weight loss and maintenance, improved insulin sensitivity and improved lipid profile. An analysis, which was based on the Nurses’Health Study, reported that moderate physical activity was associated with a reduced risk of postmenopausal … Continue reading
Chocolate can Prevent Heart-Failure
Although many studies have reported intake chocolate, especially flavanol-rich dark chocolate, can improve blood pressure and provide other cardiovascular benefits, a new study suggested chocolate can reduce the risk of heart failure. The results came from the Swedish Mammography Cohort, … Continue reading
Bevacizumab Beneficial in Newly Diagnosed Glioblastoma?
A large study of patients with newly diagnosed glioblastoma multiforme suggests that the addition of bevacizumab (Avastin) and irinotecan (Camptosar) to standard chemoradiation can extend survival (progression and overall survival) by 6 months. Bevacizumab (Avastin) is an inhibitor of vascular … Continue reading
Afatinib Extend Time to Tumor Progression in Advanced Lung Cancer
Currently, no treatment exists for lung cancer patients with epidermal growth-factor receptor (EGFR) mutation who have failed tyrosine kinase inhibitors, getifinib (Iressa) or erlotinib (Tarceva). However, an investigational drug, afatinib (BIBW 2992), was recently found to increase progression-free survival and … Continue reading
Aspirin Can Prevent From Several Common Cancers
If you are taking aspirin to prevent heart attack, you should be glad to know that you might also be protected from a variety of cancers. According to a new study published in Lancet, taking aspirin over a long period … Continue reading
Chocolate Consumption Lower Blood Pressure and Risk of Cardiovascular Disease
We previously have reported 2 studies that indicated chocolate could lower blood pressures and reduce risk of cardiovascular disease. Now, there is another study that supports the previous findings. The latest news came from a German study that evaluated the … Continue reading
FDA Panel Supports the Use of Vandetanib in Medullary Thyroid Cancer
An FDA advisory committee reported that they supported the use of AstraZeneca’s vandetanib for the treatment of patients with medullary thyroid cancer (MTC). However, they also indicated the drug should be reserved for patients who are experiencing symptoms of their … Continue reading